Cathie Wood Rubius Therapeutics, Inc. Transaction History

Ark Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$4.01 - $6.88 $1.28 Million - $2.19 Million	-318,121 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$3.74 - $9.84 $1.36 Million - $3.57 Million	-362,643 Reduced 53.27%	318,121 $1.42 Million
Q4 2019 Jan 31, 2020	SELL	$7.23 - $14.12 $362,410 - $707,779	-50,126 Reduced 6.86%	680,764 $6.47 Million
Q3 2019 Nov 12, 2019	BUY	$7.85 - $15.75 $255,030 - $511,686	32,488 Added 4.65%	730,890 $5.74 Million
Q2 2019 Jul 30, 2019	BUY	$13.5 - $19.94 $2.28 Million - $3.37 Million	168,787 Added 31.87%	698,402 $11 Million
Q1 2019 May 13, 2019	BUY	$13.27 - $18.51 $2.85 Million - $3.97 Million	214,463 Added 68.05%	529,615 $9.59 Million
Q4 2018 Feb 01, 2019	BUY	$13.83 - $22.97 $1.75 Million - $2.91 Million	126,884 Added 67.4%	315,152 $5.07 Million
Q3 2018 Nov 07, 2018	BUY	$20.06 - $26.94 $3.78 Million - $5.07 Million	188,268 New	188,268 $4.52 Million

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.